Vysioneer
Vysioneer uses lesion-level AI to tailor cancer treatment and de-risk clinical trials. The platform analyzes tumor heterogeneity and predicts drug efficacy using lesion-level data. It is an oncology AI platform for pharma and clinicians, integrating lesion-level analytics with trial workflows. The solution supports B2B drug development with FDA-cleared AI technology and builds a scalable database of lesion-level tumor characteristics. Vysioneer aims to accelerate oncology trials and improve outcomes across cancer types.
Vysioneer
Vysioneer uses lesion-level AI to tailor cancer treatment and de-risk clinical trials. The platform analyzes tumor heterogeneity and predicts drug efficacy using lesion-level data. It is an oncology AI platform for pharma and clinicians, integrating lesion-level analytics with trial workflows. The solution supports B2B drug development with FDA-cleared AI technology and builds a scalable database of lesion-level tumor characteristics. Vysioneer aims to accelerate oncology trials and improve outcomes across cancer types.